Headline News

Most breast cancer-specific deaths occur among patients diagnosed with stage I or II disease rather than more advanced disease, according to a SEER database analysis.

Biogen Inc. and Neomorph Inc. have announced a partnership geared toward research and development of molecular glue degraders to address protein accumulation related to Alzheimer’s disease and other neurologic conditions.

Patients with systemic sclerosis demonstrate lower bone mineral density compared with the general population, with significant differences reported in women aged younger than 45 years, according to data published in Rheumatology.

PHILADELPHIA — Risankizumab outperformed placebo in endoscopic improvement and remission through 52 weeks of maintenance therapy in moderately to severely active ulcerative colitis, regardless of induction outcomes, according to data.

ORLANDO — A need for allergy labeling, disparities in epinephrine access and knowledge gaps were found among Head Start centers, according to an abstract presented at the American Academy of Pediatrics National Conference & Exhibition.

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

Less than 3% of patients tested for a bacterial STI in nearly a dozen EDs were also tested for HIV, demonstrating widespread nonadherence to a CDC recommendation, according to a study presented at IDWeek.

The FDA granted de novo marketing authorization Valeda Light Delivery System for the treatment of dry age-related macular degeneration, according to a press release from LumiThera.

ORLANDO — Repeated injections of relabotulinumtoxinA over the span of a year were safe for the treatment of glabellar and lateral canthal lines, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

Results presented at the American Society for Surgery of the Hand Annual Meeting showed deep-learning AI models may be able to make accurate clinical decisions regarding whether reduction is needed for a distal radius fracture.